» Articles » PMID: 19855099

Sigma-1 Receptors Regulate Bcl-2 Expression by Reactive Oxygen Species-dependent Transcriptional Regulation of Nuclear Factor KappaB

Overview
Specialty Pharmacology
Date 2009 Oct 27
PMID 19855099
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of Bcl-2, the major antiapoptotic member of the Bcl-2 family, is under complex controls of several factors, including reactive oxygen species (ROS). The sigma-1 receptor (Sig-1R), which was recently identified as a novel molecular chaperone at the mitochondria-associated endoplasmic reticulum membrane (MAM), has been shown to exert robust cellular protective actions. However, mechanisms underlying the antiapoptotic action of the Sig-1R remain to be clarified. Here, we found that the Sig-1R promotes cellular survival by regulating the Bcl-2 expression in Chinese hamster ovary cells. Although both Sig-1Rs and Bcl-2 are highly enriched at the MAM, Sig-1Rs neither associate physically with Bcl-2 nor regulate stability of Bcl-2 proteins. However, Sig-1Rs tonically regulate the expression of Bcl-2 proteins. Knockdown of Sig-1Rs down-regulates whereas overexpression of Sig-1Rs up-regulates bcl-2 mRNA, indicating that the Sig-1R transcriptionally regulates the expression of Bcl-2. The effect of Sig-1R small interfering RNA down-regulating Bcl-2 was blocked by ROS scavengers and by the inhibitor of the ROS-inducible transcription factor nuclear factor kappaB (NF-kappaB). Knockdown of Sig-1Rs up-regulates p105, the precursor of NF-kappaB, while concomitantly decreasing inhibitor of nuclear factor-kappaBalpha. Sig-1R knockdown also accelerates the conversion of p105 to the active form p50. Lastly, we showed that knockdown of Sig-1Rs potentiates H(2)O(2)-induced apoptosis; the action is blocked by either the NF-kappaB inhibitor oridonin or overexpression of Bcl-2. Thus, these findings suggest that Sig-1Rs promote cell survival, at least in part, by transcriptionally regulating Bcl-2 expression via the ROS/NF-kappaB pathway.

Citing Articles

CNEURO-201, an Anti-amyloidogenic Agent and σ1-Receptor Agonist, Improves Cognition in the Mouse Model of Alzheimer's Disease by Multiple Actions in the Pathology.

Martinez-Orozco H, Bencomo-Martinez A, Maya-Arteaga J, Rubio-De Anda P, Sanabria-Romero F, Casas Z Int J Mol Sci. 2025; 26(3).

PMID: 39941068 PMC: 11818425. DOI: 10.3390/ijms26031301.


Sigma 1 Receptor and Its Pivotal Role in Neurological Disorders.

Shokr M, Badawi G, Elshazly S, Zaki H, Mohamed A ACS Pharmacol Transl Sci. 2025; 8(1):47-65.

PMID: 39816800 PMC: 11729429. DOI: 10.1021/acsptsci.4c00564.


Amylovis-201 is a new dual-target ligand, acting as an anti-amyloidogenic compound and a potent agonist of the chaperone protein.

Garcia-Pupo L, Crouzier L, Bencomo-Martinez A, Meunier J, Morilleau A, Delprat B Acta Pharm Sin B. 2024; 14(10):4345-4359.

PMID: 39525570 PMC: 11544189. DOI: 10.1016/j.apsb.2024.06.013.


Impact of oxidative stress induced by heavy metals on ovarian function.

Xiao C, Lai D J Appl Toxicol. 2024; 45(1):107-116.

PMID: 38938153 PMC: 11634564. DOI: 10.1002/jat.4664.


Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential.

Allen J, Dames S, Foldi C, Shultz S Mol Psychiatry. 2024; 29(3):671-685.

PMID: 38177350 DOI: 10.1038/s41380-023-02360-0.


References
1.
Rong Y, Aromolaran A, Bultynck G, Zhong F, Li X, McColl K . Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol Cell. 2008; 31(2):255-65. PMC: 3660092. DOI: 10.1016/j.molcel.2008.06.014. View

2.
Krajewski S, Tanaka S, Takayama S, Schibler M, Fenton W, Reed J . Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 1993; 53(19):4701-14. View

3.
Lam M, Dubyak G, Chen L, Nunez G, Miesfeld R, Distelhorst C . Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc Natl Acad Sci U S A. 1994; 91(14):6569-73. PMC: 44244. DOI: 10.1073/pnas.91.14.6569. View

4.
Oltvai Z, Milliman C, Korsmeyer S . Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993; 74(4):609-19. DOI: 10.1016/0092-8674(93)90509-o. View

5.
Fontanilla D, Johannessen M, Hajipour A, Cozzi N, Jackson M, Ruoho A . The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009; 323(5916):934-7. PMC: 2947205. DOI: 10.1126/science.1166127. View